Every year, more than one million scientific articles are published in the life sciences. Two-thirds of them include ...

The most important financial reporting period is the current period the company is reporting on. Business leaders want to ...

Hospitals nationwide are grappling with high patient volumes, staffing shortages and inefficient capacity management — all while being asked to deliver timely, high-quality care. During a recent ...

Opinion: Haynes Boone’s Zachary Jacobs says a growing backlog of high-quality assets and deal structures that balance risk ...

The study’s authors note that small neural networks — simplified versions of the neural networks typically used in commercial ...

Learn why data lineage is necessary for compliance, how it works, and what steps you need to take to implement and maintain ...

AI teams face constant pressure to make fast, informed decisions. Thankfully, visual collaboration tools simplify complex processes, align team members, and cla ...

Pharma FDA misses another approval decision target date, this time for GSK's Nucala in COPD By Fraiser Kansteiner May 8, 2025 1:39pm GSK Nucala chronic obstructive pulmonary disease (COPD) U.S. FDA ...

An approval decision for Stealth BioTherapeutics’ investigational treatment for an ultra-rare genetic disease has been delayed—again—this time, with no new decision date given. | An approval ...

Grayscale Bitcoin Trust ETF faces criticism for high fees, prompting a shift to the lower-cost Grayscale Bitcoin Mini Trust ETF. Learn more on GBTC ETF here.